Defund prevention, then bankroll crisis response.
Once again, the United States finds itself writing emergency checks for a crisis it might have helped prevent, as an Ebola outbreak claims over a hundred lives in the Democratic Republic of Congo. The pattern echoes COVID-19 with uncomfortable precision: defund the quiet, unglamorous infrastructure of global health, then spend far more when silence becomes catastrophe. History has already calculated the cost of this approach in trillions of dollars and millions of lives, yet the political will to invest before a crisis materializes remains elusive. The question is not whether prevention is cheaper than response — it demonstrably is — but whether a nation can sustain attention to dangers it cannot yet see.
- More than 100 people have died in one of the worst Ebola outbreaks on record in the Democratic Republic of Congo, and the crisis is still escalating.
- The U.S. gutted USAID funding for African disease surveillance and laboratory networks — the very systems built to catch outbreaks early — then pledged over $200 million in emergency aid once the situation became undeniable.
- America's withdrawal from the WHO has severed critical channels of outbreak intelligence, leaving the country slower to detect and respond to exactly the kind of threat now unfolding in Congo.
- Public health experts warn that this reactive cycle — cut prevention, fund crisis — costs exponentially more in dollars and lives than sustained proactive investment ever would.
- The path forward requires years of committed funding for vaccines, labs, and epidemiological training before the next emergency arrives, not emergency appropriations after people are already dying.
The United States is watching an Ebola outbreak claim over 100 lives in the Democratic Republic of Congo and responding the way it responded to COVID-19: waiting until the crisis is undeniable, then spending heavily to contain it. Public health experts recognize the pattern immediately. The diseases differ, the circumstances differ, but the American instinct remains the same — react after the fact rather than prepare before it happens.
The economic logic of this approach has never held up, and COVID-19 proved it at catastrophic scale. The pandemic cost the American economy trillions through healthcare spending, lost productivity, and economic shutdowns. The investments that might have slowed or prevented such a crisis — laboratory networks, surveillance systems, trained epidemiologists — would have cost a fraction of that sum. But they require sustained commitment during calm periods, precisely when political will tends to disappear.
The U.S. chose a different path. It cut billions from USAID, eliminating support for African laboratory facilities, surveillance systems, and the epidemiologists trained to respond quickly. Then, as the Ebola outbreak escalated, it pledged over $200 million in emergency aid. The reversal is stark: defund prevention, then bankroll the crisis. Had the original investments held, that money might never have been necessary.
COVID-19 also demonstrated how much global partnerships matter. The WHO declared a public health emergency in late January 2020; countries that acted on that signal immediately, like South Korea, ran thousands of tests daily within weeks. The U.S. moved slowly and paid dearly. Yet this year, the U.S. withdrew from the WHO entirely — meaning critical alerts now arrive late or not at all, outbreak intelligence is diminished, and the coordination that enables early detection is harder to achieve.
The lesson should be clear by now: prevention only works if investment arrives before the crisis does. Infectious diseases cross borders as easily as travelers do, and the Ebola outbreak in Congo — whatever its ultimate scale — is another reminder that the world's interconnection demands constant vigilance. Reactive scrambling is not a strategy. It is an expensive, recurring choice to learn the same lesson again.
The United States is watching an Ebola outbreak unfold in the Democratic Republic of Congo—over 100 confirmed deaths so far—and responding the same way it did when COVID-19 arrived nearly six years ago: waiting until the crisis is undeniable, then spending heavily to contain it. The pattern is familiar enough to frustrate public health experts. The diseases are different. The circumstances are different. But the American instinct remains unchanged: react after the fact rather than prepare before it happens.
The economic logic of this approach has never made sense, and COVID-19 proved it catastrophically. The pandemic cost the American economy trillions of dollars—through direct healthcare spending, lost productivity, broken supply chains, labor shortages, and economic shutdowns. By contrast, the investments that might have prevented or slowed such a crisis would have cost a fraction of that sum. Building laboratory networks, establishing disease surveillance systems, training epidemiologists, strengthening public health infrastructure—these are the unglamorous, preventive measures that save money and lives. Yet they require sustained commitment in moments when no crisis is visible, which is precisely when political will tends to evaporate.
The United States chose a different path. It cut billions of dollars from USAID, the foreign aid agency that funds exactly the kind of work that might have detected Ebola earlier and contained it faster. Those cuts eliminated support for laboratory facilities across Africa, surveillance systems designed to spot outbreaks before they spread, and the training of epidemiologists who would have the expertise to respond quickly. Then, as the Ebola outbreak escalated into one of the worst on record, the U.S. pledged over 200 million dollars in emergency aid to Africa. The reversal is stark: defund prevention, then bankroll crisis response. Had the original investments held, that 200 million might never have been necessary, and more people might still be alive.
The failure extends beyond funding. The COVID-19 pandemic demonstrated how critical global health partnerships are—how early warning systems, coordinated testing, and shared intelligence can slow transmission and save lives. The World Health Organization began issuing technical guidance in early January 2020 and declared a public health emergency of international concern on January 30. Countries that took that signal seriously, like South Korea, ramped up testing capacity immediately, running 10,000 tests daily by early 2020. The United States moved slowly, delayed its testing rollout, and allowed the virus to spread faster than the public health system could manage.
Yet despite that lesson, the United States withdrew from the WHO earlier this year. The consequences are direct: critical global health alerts now arrive late or not at all. The U.S. has less access to outbreak intelligence. Fewer resources flow to outbreak response centers. The coordination that might have strengthened surveillance systems, enabled earlier detection of Ebola, and prevented cases and deaths is now harder to achieve. A sustained partnership with the WHO and other nations could have positioned the U.S. as a leader in global disease detection and response. Instead, the country has stepped back at the moment when such collaboration matters most.
The deeper lesson is one that should have been learned by now: prevention works, but only if you invest in it before the crisis arrives. Vaccines, laboratories, surveillance systems—these require years of sustained funding and attention, not emergency appropriations after people are already dying. Infectious diseases do not respect borders. A threat abroad becomes a threat at home through the simple fact of modern travel. The Ebola outbreak in Congo may not pose the pandemic threat that COVID-19 did, but it serves as a reminder that the world is interconnected in ways that demand constant vigilance, not reactive scrambling.
Citas Notables
Successful prevention and outbreak preparedness do not manifest after cases and deaths are already recorded, but years before by investing in vaccines, laboratories and cutting edge surveillance systems.— Public health experts cited in analysis
La Conversación del Hearth Otra perspectiva de la historia
Why does the U.S. keep making the same choice—cutting prevention funding, then spending more on emergency response?
Because prevention is invisible. You cut funding and nothing happens. No outbreak occurs that year, or the next. It looks like you saved money. Then a crisis hits and you have no choice but to spend whatever it takes. By then, the damage is already done.
But the math is clear—prevention costs less than response. Shouldn't that be enough?
The math is clear to epidemiologists and economists. It's not clear to budget committees in an election year. Prevention is a long-term commitment. Response is a headline. Politicians get credit for action, not for crises that never happened.
What changes if the U.S. stays in the WHO instead of withdrawing?
You get early warning. You have a seat at the table when outbreaks are detected. You can coordinate testing, share data, move resources where they're needed fastest. Withdrawing means you're flying blind, getting information late, and working alone when you need partners most.
Is the Ebola outbreak in Congo a warning about what could happen here?
It's a reminder that distance doesn't protect you anymore. A plane from Kinshasa to Brussels to New York takes less than 24 hours. The virus doesn't care about borders. If you're not helping contain it there, you're betting it won't reach here. That's not a strategy.
What would real preparedness look like?
It would mean funding surveillance systems in Africa not because there's an outbreak, but because outbreaks happen. It would mean keeping trained epidemiologists on staff, not hiring them in a panic. It would mean staying in global health partnerships even when nothing is happening. It's boring. It's unglamorous. It works.